Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUTSELSKAB KLINIK FOR FYSIOTERAPI NORDBORG ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8%   Bankruptcy risk   5.9% 5.1% 4.4% 8.5% 4.5% 3.2% 18.5% 11.5%   Credit score (0-100)   41 45 48 29 45 55 7 4   Credit rating   BB BB BB B BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,156 943 753 674 663 805 0.0 0.0   EBITDA   231 424 331 76.0 120 323 0.0 0.0   EBIT   24.4 218 182 -51.0 120 323 0.0 0.0   Pre-tax profit (PTP)   24.4 190.0 181.0 -55.0 116.0 325.3 0.0 0.0   Net earnings   24.4 194.0 141.0 -44.0 90.0 251.4 0.0 0.0   Pre-tax profit without non-rec. items   24.4 190 181 -55.0 116 325 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   101 22.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -113 81.0 222 177 268 519 119 119   Interest-bearing liabilities   0.0 291 170 92.0 264 231 0.0 0.0   Balance sheet total (assets)   903 429 507 344 574 858 119 119   Net Debt   -298 262 164 -80.0 -8.0 -36.6 -119 -119     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,156 943 753 674 663 805 0.0 0.0   Gross profit growth   14.1% -18.4% -20.1% -10.5% -1.6% 21.5% -100.0% 0.0%   Employees   0 2 1 1 1 1 0 0   Employee growth %   0.0% 0.0% -50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   903 429 507 344 574 858 119 119   Balance sheet change%   -20.0% -52.5% 18.2% -32.1% 66.9% 49.4% -86.2% 0.0%   Added value   230.8 424.0 331.0 76.0 247.0 323.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -377 -412 -298 -254 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.1% 23.1% 24.2% -7.6% 18.1% 40.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.1% 30.2% 41.2% -11.8% 26.1% 47.6% 0.0% 0.0%   ROI %   2.3% 32.4% 50.5% -15.1% 30.0% 53.2% 0.0% 0.0%   ROE %   2.4% 39.4% 93.1% -22.1% 40.4% 63.9% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   -11.1% 18.9% 43.8% 51.5% 46.7% 60.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -129.2% 61.8% 49.5% -105.3% -6.7% -11.3% 0.0% 0.0%   Gearing %   0.0% 359.3% 76.6% 52.0% 98.5% 44.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 19.2% 5.2% 3.8% 2.2% 6.4% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   9.6 0.4 1.3 1.9 1.8 2.5 0.0 0.0   Current Ratio   9.6 0.4 1.3 1.9 1.8 2.5 0.0 0.0   Cash and cash equivalent   298.2 29.0 6.0 172.0 272.0 267.5 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   377.0 -195.0 73.0 155.0 246.0 496.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 212 331 76 247 323 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 212 331 76 120 323 0 0   EBIT / employee   0 109 182 -51 120 323 0 0   Net earnings / employee   0 97 141 -44 90 251 0 0